RACHEL SMITH: Open Payments
NPI 1366091209 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 23 payments from 12 companies in 2025. Trend: 2023 $255 · 2024 $528 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $166 |
| Grifols USA, LLC | 4 | $145 |
| Merck Sharp & Dohme LLC | 3 | $86 |
| Verona Pharma, Inc. | 3 | $78 |
| United Therapeutics Corporation | 3 | $76 |
| Viatris Specialty LLC | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
Products named: General - Therapies, Prolastin-C Liquid, Ohtuvayre, Tyvaso, WINREVAIR, YUPELRI, KEYTRUDA, NINLARO.
Industry payments across TN — which companies pay providers there.
